Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (121-130 of 574) with videos related to

Pageof 58
Sort By:
Emerging Infectious Diseases|December 21, 2006
KPC type beta-lactamase, rural PennsylvaniaJonathan Pope, Jennifer Adams, Yohei Doi, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2006
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from BrazilYohei Doi, Doroti de Oliveira Garcia, Jennifer Adams, et al.
British Journal of Clinical Pharmacology|August 12, 2011
Therapeutic drug monitoring of antimicrobialsJason A Roberts, Ross Norris, David L Paterson, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidenceBurcu Isler, Zhenya Welyczko, Nicholas Jorgensen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2025
Practical considerations for implementation of syndromic panel and diagnostic stewardship in the era of syndromic panel testingShradha Subedi, Patrick N A Harris, Lisa Hall, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 15, 2015
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter OsteomyelitisAdam Stewart, Bianca Graves, Krispin Hajkowicz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2014
Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic reviewBenjamin Lazarus, David L Paterson, Joanne L Mollinger, et al.
Plos One|June 30, 2011
Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infectionsSebastiaan J van Hal, Mark Jones, Iain B Gosbell, et al.
Plos One|September 24, 2010
Cost-effectiveness of a central venous catheter care bundleKate A Halton, David Cook, David L Paterson, et al.
Clinical Pharmacokinetics|December 15, 2010
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patientsMarta Ulldemolins, Jason A Roberts, Jordi Rello, et al.
Pageof 58

Showing results (121-130 of 574) with videos related to

Sort By:
Pageof 58
Emerging Infectious Diseases|December 21, 2006
KPC type beta-lactamase, rural PennsylvaniaJonathan Pope, Jennifer Adams, Yohei Doi, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2006
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from BrazilYohei Doi, Doroti de Oliveira Garcia, Jennifer Adams, et al.
British Journal of Clinical Pharmacology|August 12, 2011
Therapeutic drug monitoring of antimicrobialsJason A Roberts, Ross Norris, David L Paterson, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidenceBurcu Isler, Zhenya Welyczko, Nicholas Jorgensen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2025
Practical considerations for implementation of syndromic panel and diagnostic stewardship in the era of syndromic panel testingShradha Subedi, Patrick N A Harris, Lisa Hall, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 15, 2015
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter OsteomyelitisAdam Stewart, Bianca Graves, Krispin Hajkowicz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2014
Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic reviewBenjamin Lazarus, David L Paterson, Joanne L Mollinger, et al.
Plos One|June 30, 2011
Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infectionsSebastiaan J van Hal, Mark Jones, Iain B Gosbell, et al.
Plos One|September 24, 2010
Cost-effectiveness of a central venous catheter care bundleKate A Halton, David Cook, David L Paterson, et al.
Clinical Pharmacokinetics|December 15, 2010
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patientsMarta Ulldemolins, Jason A Roberts, Jordi Rello, et al.
Pageof 58